The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents.

被引：0
|
作者：
La-Beck, N. M.
Wu, H.
Infante, J. R.
Jones, S. F.
Burris, H. A., III
Keedy, V. L.
Kodaira, H.
Ikeda, S.
Ramanathan, R. K.
Zamboni, W.
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[6] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[7] Yakult Honsha, Tokyo, Japan
[8] Virginia G Piper Canc Ctr & TGen, Scottsdale, AZ USA
[9] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13003
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Relationship between serum hormone levels and pharmacokinetics (PK) of PEGylated liposomal doxorubicin (PLD) in patients with refractory ovarian cancer
    Kumar, Parag
    Caron, Whitney P.
    Song, Gina
    Gallagher, Katie
    Clarke-Pearson, Daniel L.
    Brewster, Wendy R.
    Van Le, Linda
    Bae-Jump, Victoria
    Gehrig, Paola A.
    Zamboni, William C.
    CANCER RESEARCH, 2012, 72
  • [22] Evaluation of recombinant arginine deiminases of Pseudomonas putida and Mycoplasma arginini as anticancer agents.
    Arunakumari, A
    Sarkar, S
    Wang, M
    Filpula, D
    Lee, LS
    Gilbert, C
    Bradley, P
    Clark, M
    Shorr, R
    FASEB JOURNAL, 1996, 10 (03): : 3094 - 3094
  • [23] Anticancer effects and bioavailability of dietary flavonoid agents.
    Franke, AA
    Custer, LJ
    Mordan, LJ
    Cooney, RV
    Harwood, PJ
    Wang, W
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 114 - AGFD
  • [24] RXR selective retinoids as potential anticancer agents.
    Nadzan, AM
    Boehm, MF
    Zhang, L
    Badea, BA
    Koch, SC
    Dardashti, L
    White, SK
    Kallel, EA
    Mais, DE
    Berger, E
    Suto, CM
    Gottardis, M
    McClurg, MR
    Heyman, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 124 - MEDI
  • [25] L-Nucleosides as antiviral and anticancer agents.
    Chu, CK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U202 - U202
  • [26] Quantum chemical studies of inorganic anticancer agents.
    Deubel, DV
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U708 - U708
  • [27] Design and synthesis of benzimidazole derivatives as anticancer agents.
    Parikh, AR
    Parekh, HH
    Vekariya, NG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U652 - U652
  • [28] Citrus limonoids: Increasing potential, as anticancer agents.
    Miller, EG
    Taylor, SE
    Berry, CW
    Zimmermann, JA
    Hasegawa, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U40 - U40
  • [29] Factors affecting the pharmacokinetics (PK) and pharmacodynamics (PD) of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
    Wu, Huali
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Burris, Howard A., III
    Chan, Emily
    Keedy, Vicki L.
    Bendell, Johanna C.
    Zamboni, Beth A.
    Kodaira, Hiroshi
    Ikeda, Satoshi
    Zamboni, William C.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [30] Pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) given alone and with bevacizumab (B) in patients with recurrent epithelial ovarian cancer (rEOC).
    Muggia, F.
    Safra, T.
    Borgato, L.
    Gandhi, A.
    Mancinc, G.
    Gabizon, A.
    Liebes, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345